Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LGALS8 | O00214 | 1/20 | 0.49 |
| ▸ | LGALS3 | P17931 | 1/20 | 0.49 |
| ▸ | LGALS4 | P56470 | 1/20 | 0.49 |
| ▸ | IGF2R | P11717 | 7/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2621537 | 1.00 | LGALS8 (0.49) | LGALS8LGALS3LGALS4IGF2RGAA | |
| SCHEMBL15730328 | 0.91 | LGALS8 (0.54) | LGALS8LGALS3LGALS4IGF2R | |
| SCHEMBL14088869 | 0.90 | IGF2R (0.58) | LGALS8LGALS3LGALS4IGF2R | |
| SCHEMBL14088867 | 0.89 | IGF2R (0.57) | LGALS8LGALS3LGALS4IGF2R | |
| SCHEMBL14088870 | 0.89 | IGF2R (0.57) | LGALS8LGALS3LGALS4IGF2R | |
| SCHEMBL9610954 | 0.88 | LGALS8 (0.51) | LGALS8LGALS3LGALS4IGF2RGAA | |
| SCHEMBL22698252 | 0.85 | LGALS8 (0.56) | LGALS8LGALS3LGALS4IGF2RGAA | |
| SCHEMBL21847946 | 0.85 | LGALS8 (0.56) | LGALS8LGALS3LGALS4IGF2RGAA | |
| SCHEMBL7567858 | 0.85 | LGALS8 (0.56) | LGALS8LGALS3LGALS4IGF2RGAA | |
| SCHEMBL10062529 | 0.85 | LGALS8 (0.56) | LGALS8LGALS3LGALS4IGF2RGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120100097-A1 | CELLULOSE SUPPORT CONTAINING D-MANNOSE DERIVATIVES | AHLSTROM CORPORATION (FI) | 2012-04-26 | — | — | US | claimed |
| EP-2424487-A2 | CELLULOSE SUPPORT CONTAINING D-MANNOSE DERIVATIVES | Ahlstrom Corporation (FI) | 2012-03-07 | — | — | EP | claimed |
| WO-2010125239-A2 | CELLULOSE SUPPORT CONTAINING D-MANNOSE DERIVATIVES | AHLSTROM CORPORATION (FI) | 2010-11-04 | — | — | WO | claimed |
| US-20120100097-A1 | CELLULOSE SUPPORT CONTAINING D-MANNOSE DERIVATIVES | AHLSTROM CORPORATION (FI) | 2012-04-26 | — | — | US | disclosed |
| EP-2424487-A2 | CELLULOSE SUPPORT CONTAINING D-MANNOSE DERIVATIVES | Ahlstrom Corporation (FI) | 2012-03-07 | — | — | EP | disclosed |
| WO-2010125239-A2 | CELLULOSE SUPPORT CONTAINING D-MANNOSE DERIVATIVES | AHLSTROM CORPORATION (FI) | 2010-11-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120100097-A1 | CELLULOSE SUPPORT CONTAINING D-MANNOSE DERIVATIVES | ALG1, CHIT1, MAN2A1 | LGALS8 1070/4885LGALS3 602/4885LGALS4 219/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.